Growth differentiation factor 6 derived from mesenchymal stem/ stromal cells reduces age-related functional deterioration in multiple tissues

5Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

The senescence-associated secretory phenotype (SASP) has attracted attention as a mechanism that connects cellular senescence to tissue dysfunction, and specific SASP factors have been identified as systemic pro-aging factors. However, little is known about the age-dependent changes in the secretory properties of stem cells. Young, but not old, mesenchymal stem/stromal cells (MSCs) are a well-known source of critical regenerative factors, but the identity of these factors remains elusive. In this study, we identified growth differentiation factor 6 (Gdf6; also known as Bmp13 and CDMP- 2) as a regenerative factor secreted from young MSCs. The expression of specific secretory factors, including Gdf6, was regulated by the microRNA (miRNA) miR-17, whose expression declined with age. Upregulation of Gdf6 restored the osteogenic capacity of old MSCs in vitro and exerted positive effects in vivo on aging-associated pathologies such as reduced lymphopoiesis, insufficient muscle repair, reduced numbers of neural progenitors in the brain, and chronic inflammation. Our results suggest that manipulation of miRNA could enable control of the SASP, and that regenerative factors derived from certain types of young cells could be used to treat geriatric diseases.

Cite

CITATION STYLE

APA

Hisamatsu, D., Ohno-Oishi, M., Nakamura, S., Mabuchi, Y., & Naka-Kaneda, H. (2016). Growth differentiation factor 6 derived from mesenchymal stem/ stromal cells reduces age-related functional deterioration in multiple tissues. Aging, 8(6), 1259–1275. https://doi.org/10.18632/aging.100982

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free